These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12005097)

  • 1. Fatal disseminated Candida lusitaniae infection in an infant with chronic granulomatous disease.
    Levy O; Bourquin JP; McQueen A; Cantor AB; Lachenauer C; Malley R
    Pediatr Infect Dis J; 2002 Mar; 21(3):262-4. PubMed ID: 12005097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Keratitis caused by Candida glabrata in a patient with chronic granulomatous disease.
    Djalilian AR; Smith JA; Walsh TJ; Malech HL; Robinson MR
    Am J Ophthalmol; 2001 Nov; 132(5):782-3. PubMed ID: 11704043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful interferon-gamma therapy in a chronic granulomatous disease (CGD) patient suffering from Staphylococcus aureus hepatic abscess and invasive Candida albicans infection.
    Malmvall BE; Follin P
    Scand J Infect Dis; 1993; 25(1):61-6. PubMed ID: 8460351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida lusitaniae and chronic granulomatous disease.
    Estrada B; Mancao MY; Polski JM; Figarola MS
    Pediatr Infect Dis J; 2006 Aug; 25(8):758-9. PubMed ID: 16874186
    [No Abstract]   [Full Text] [Related]  

  • 5. Candida lusitaniae catheter-related sepsis.
    Pietrucha-Dilanchian P; Lewis RE; Ahmad H; Lechin AE
    Ann Pharmacother; 2001 Dec; 35(12):1570-4. PubMed ID: 11793623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida lusitaniae: a new opportunistic pathogen of the urinary tract.
    Baker JG; Nadler HL; Forgacs P; Kurtz SR
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):145-9. PubMed ID: 6713809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections.
    Williamson PR; Kwon-Chung KJ; Gallin JI
    Clin Infect Dis; 1992 May; 14(5):1023-6. PubMed ID: 1318085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of resistance to amphotericin B in Candida lusitaniae infecting a human.
    Pappagianis D; Collins MS; Hector R; Remington J
    Antimicrob Agents Chemother; 1979 Aug; 16(2):123-6. PubMed ID: 290351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Candida endophthalmitis accompanying Candida lusitaniae bloodstream infection: A case report.
    Yamamoto S; Ikeda M; Fujimoto F; Okamoto K; Wakabayashi Y; Sato T; Tatsuno K; Kaburaki T; Yoshida S; Okugawa S; Koike K; Moriya K
    J Infect Chemother; 2018 Feb; 24(2):147-149. PubMed ID: 29102349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotherapy in chronic familial granulomatosis].
    Vilde JL; Leport C
    Pathol Biol (Paris); 1990 Apr; 38(4):294-7. PubMed ID: 2198524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B dosage for disseminated candidiasis in premature infants.
    Hall JE; Cox F; Karlson K; Robertson A
    J Perinatol; 1987; 7(3):194-8. PubMed ID: 3332892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of invasive pulmonary aspergillosis in chronic granulomatous disease with orally administered itraconazole suspension.
    Spencer DA; John P; Ferryman SR; Weller PH; Darbyshire P
    Am J Respir Crit Care Med; 1994 Jan; 149(1):239-41. PubMed ID: 8111588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida lusitaniae infections in the era of fluconazole availability.
    Hawkins JL; Baddour LM
    Clin Infect Dis; 2003 Jan; 36(2):e14-8. PubMed ID: 12522762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of interferon-gamma for prevention of severe infection in X-linked chronic granulomatous disease.
    Ma HR; Mu SC; Yang YH; Chen CM; Chiang BL
    J Formos Med Assoc; 2003 Mar; 102(3):189-92. PubMed ID: 12783137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic granulomatous disease--a report in two Malay families.
    Mohd Noh L; Noah RM; Wu LL; Nasuruddin BA; Junaidah E; Ooi CP; Rose I
    Singapore Med J; 1994 Oct; 35(5):505-8. PubMed ID: 7701372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked chronic granulomatous disease: report of one case.
    Weng JD; Shyur SD
    Acta Paediatr Taiwan; 2004; 45(3):163-7. PubMed ID: 15493736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pulmonary aspergillosis in chronic granulomatous disease: response to systemic prednisolone treatment and locally applied amphotericin B.
    Güler N; Yalçin I; Salman N; Oneş U
    Turk J Pediatr; 1994; 36(4):341-5. PubMed ID: 7825243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.
    Atkinson BJ; Lewis RE; Kontoyiannis DP
    Med Mycol; 2008 Sep; 46(6):541-6. PubMed ID: 19180749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
    Minari A; Hachem R; Raad I
    Clin Infect Dis; 2001 Jan; 32(2):186-90. PubMed ID: 11170906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.